The Chemours' (CC) CEO Mark Vergnano on Q3 2017 Results - Earnings Call Transcript

Nov. 04, 2017 2:46 AM ETThe Chemours Company (CC) Stock
SA Transcripts profile picture
SA Transcripts
150.87K Followers

Q3: 2017-11-02 Earnings Summary

EPS of $1.12 beats by $0.08 | Revenue of $1.58B (13.30% Y/Y) misses by $4.05M

The Chemours Company (NYSE:CC) Q3 2017 Earnings Conference Call November 3, 2017 8:30 AM ET

Executives

Alisha Bellezza - Treasurer & Director, IR
Mark Vergnano - President & CEO
Mark Newman - SVP & CFO

Analysts

Christopher Evans - Goldman Sachs
P.J. Juvekar - Citigroup
Duffy Fischer - Barclays
Don Carson - Susquehanna Financial
Jeff Zekauskas - JP Morgan
John Roberts - UBS
Roger Spitz - Bank of America/Merrill Lynch
Robert Koort - Goldman Sachs
Jason Weinberg - Columbia Threadneedle

Operator

Good morning. My name is Sheryl and I will be your conference operator today. At this time, I would like to welcome everyone to The Chemours Company Third Quarter Earnings Call. [Operator Instructions] Ms. Alisha Bellezza, Treasurer and Director of Investor Relations, you may begin your conference.

Alisha Bellezza

Thank you and good morning everyone. Welcome to The Chemours Company 2017 third quarter earnings conference call. I am joined today by Mark Vergnano, President and Chief Executive Officer, who will begin the call with the highlights of our third quarter; and Mark Newman, Senior Vice President and Chief Financial Officer, who will review our financial performance and liquidity positions. Mark Vergnano will then review our business result and conclude the call with our outlook.

Before we begin, let me remind you that comments on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including those described in the documents Chemours has filed with the SEC. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information.

During

Recommended For You

About CC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CC